Invention Grant
US08007783B2 Quality of life for hepatitis C patients with a formulation for administration to the oral mucosa including Lactobacillus delbrueckii subsp. bulgaricus and N-acetyl D-glucosamine
有权
具有用于口服粘膜给药的制剂的丙型肝炎患者的生活质量，包括德氏乳杆菌（Lactobacillus delbrueckii subsp。） 保加利亚和N-乙酰基D-葡糖胺
- Patent Title: Quality of life for hepatitis C patients with a formulation for administration to the oral mucosa including Lactobacillus delbrueckii subsp. bulgaricus and N-acetyl D-glucosamine
- Patent Title (中): 具有用于口服粘膜给药的制剂的丙型肝炎患者的生活质量，包括德氏乳杆菌（Lactobacillus delbrueckii subsp。） 保加利亚和N-乙酰基D-葡糖胺
-
Application No.: US11508633Application Date: 2006-08-22
-
Publication No.: US08007783B2Publication Date: 2011-08-30
- Inventor: Carl Miller
- Applicant: Carl Miller
- Agency: Gearhart Law, LLC
- Main IPC: C12N1/00
- IPC: C12N1/00 ; C12N1/20
Abstract:
Disclosed are quick dissolve tablets, each including Lactobacillus delbrueckii subsp bulgaricus (LBD) and N-acetyl-glucosamine (NAG), as well as excipients, for oral mucosal administration, for improving the quality of life of Hepatitis C patients. Any formulation suitable for oral mucosal administration can be employed for administering the active ingredients in a sufficient dosage for therapeutic effect, one such formulation being: 50 mg of Lactobacillus delbrueckii subsp bulgaricus lysate strain YB-I 10 mg of N-acetyl D-glucosamine. Excipients can include one or more of, maltodextrin; xanthan gum; acesulfam K; lemon powder and a flavoring, e.g., juice; Mannitol TL-32-04, Microcrystalline Cellulose and Carrageenan, Fructose, PVP-XL TL-11-04, Gellan Gum, Citrus TL 1-04, Orange TL 19-04, Sucrolose TL-13-04, and Mg ST TL-13-04.
Public/Granted literature
Information query
